Conference Reports for NATAP

Back

Third International Workshop on HIV and Women January 14-15, 2013 Toronto     SAFETY AND EFFICACY OF LOPINAVIR/RITONAVIR-BASED ANTIRETROVIRAL THERAPY IN PREGNANT WOMEN: A SYSTEMATIC REVIEW - (01/17/12)   Total and Unbound Darunavir (DRV) Pharmacokinetics (PK) in HIV-1-Infected Pregnant Women - (01/16/12)   Nine-Study Review Raises No Lopinavir Efficacy or Safety Concerns in Pregnancy - written by Mark Mascolini (01/16/12)   High Rate of Obstetric Problems in HIV+ Ottawa Women With Free Care - written by Mark Mascolini (01/16/12)   Twice-Daily Darunavir/Ritonavir in Regimens for Pregnant Women - written by Mark Mascolini (01/16/12)   Risk of Progression to Fibrosis Twice Higher in Women Than Men With HCV/HIV - written by Mark Mascolini (01/16/12)   Lower Cognitive Scores in Women With HCV/HIV Than With HIV Alone - written by Mark Mascolini (01/15/12)   Psych and Substance Abuse Disorders Frequent and Persistent in US Mothers With HIV - written by Mark Mascolini (01/15/12)   Depression Scores Rise Yearly After Age 40 for HIV+ Women But Not Men - written by Mark Mascolini (01/15/12)   HIV Transmission Risk Essentially 0 if Heterosexual Partner Has Undetectable Viral Load - written by Mark Mascolini (01/15/12)